These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 11358199)

  • 21. [Neuroleptic malignant syndrome after withdrawal of levopoda].
    Cedeno-Veloz B; Areosa Sastre A
    Rev Esp Geriatr Gerontol; 2018; 53(5):299-300. PubMed ID: 29628214
    [No Abstract]   [Full Text] [Related]  

  • 22. Neuroleptic malignant syndrome associated with bromocriptine withdrawal in Parkinson's disease--a case report.
    Wu YF; Kan YS; Yang CH
    Gen Hosp Psychiatry; 2011; 33(3):301.e7-8. PubMed ID: 21601731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroleptic malignant syndrome-like, or--dopaminergic malignant syndrome--due to levodopa therapy withdrawal. Clinical features in 11 patients.
    Serrano-Dueñas M
    Parkinsonism Relat Disord; 2003 Jan; 9(3):175-8. PubMed ID: 12573874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S; Kornreich C; Choubani Z; Gourevitch R
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An uncommon adverse effect of levodopa withdrawal in a patient taking antipsychotic medication: neuroleptic malignant-like syndrome.
    Man SP
    Hong Kong Med J; 2011 Feb; 17(1):74-6. PubMed ID: 21282831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Rhabdomyolysis in neuroleptic therapy: an abortive malignant neuroleptic syndrome?].
    Peschel O; Kurtz G; Müller-Felber W; Modell S
    Nervenarzt; 1994 Oct; 65(10):718-21. PubMed ID: 7808573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroleptic malignant syndrome postoperative onset due to levodopa withdrawal.
    Young CC; Kaufman BS
    J Clin Anesth; 1995 Dec; 7(8):652-6. PubMed ID: 8747565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pathological gambling behavior in a patient with Parkinson's disease treated with levodopa and bromocriptine].
    Montastruc JL; Schmitt L; Bagheri H
    Rev Neurol (Paris); 2003 Apr; 159(4):441-3. PubMed ID: 12773874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroleptic malignant syndrome: a case report.
    Fekadu A; Wakwoya A
    Ethiop Med J; 1999 Jul; 37(3):195-8. PubMed ID: 11957317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. It was not just a heatwave! Neuroleptic malignant-like syndrome in a patient with Parkinson's disease.
    Douglas A; Morris J
    Age Ageing; 2006 Nov; 35(6):640-1. PubMed ID: 16943262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Neuroleptic malignant syndrome--a case report on diagnosis, differential diagnosis and therapy of a life threatening complication of treatment with neuroleptics].
    Staud L; Pflug B
    Psychiatr Prax; 1992 Jul; 19(4):114-8. PubMed ID: 1354879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A collaborative study on the malignant syndrome in Parkinson's disease and related disorders.
    Takubo H; Harada T; Hashimoto T; Inaba Y; Kanazawa I; Kuno S; Mizuno Y; Mizuta E; Murata M; Nagatsu T; Nakamura S; Yanagisawa N; Narabayashi H
    Parkinsonism Relat Disord; 2003 Apr; 9 Suppl 1():S31-41. PubMed ID: 12735913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Differential diagnosis of acute life threatening catatonia and malignant neuroleptic syndrome--a case report].
    Hermle L; Oepen G
    Fortschr Neurol Psychiatr; 1986 Jun; 54(6):189-95. PubMed ID: 2873091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Neuroleptic malignant syndrome: a review of literature].
    Crespo Facorro B; Carbonell Masia C
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995; 23(5):273-8. PubMed ID: 8553925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroleptic malignant syndrome.
    Parikh AM; Camara EG
    Am Fam Physician; 1988 Feb; 37(2):296-8. PubMed ID: 3278570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroleptic malignant syndrome and acute myocardial infarction: case report and review.
    Freedman MD
    Md Med J; 1997 Aug; 46(7):357-9. PubMed ID: 9260471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroleptic malignant syndrome in parkinsonian patients: risk factors.
    Kuno S; Mizuta E; Yamasaki S
    Eur Neurol; 1997; 38 Suppl 2():56-9. PubMed ID: 9387804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Levodopa withdrawal syndrome identical to neuroleptic malignant syndrome.
    Gibb WR; Griffith DN
    Postgrad Med J; 1986 Jan; 62(723):59-60. PubMed ID: 3797365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prevention and treatment of malignant syndrome in patients with Parkinson's disease].
    Kuno S
    Nihon Rinsho; 2004 Sep; 62(9):1721-4. PubMed ID: 15462391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Increase in serum creatine phosphokinase following administration of talipexole hydrochloride].
    Osumi E; Imai T
    Rinsho Shinkeigaku; 2000 Oct; 40(10):1041-3. PubMed ID: 11296371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.